Contact Us

Phone
1300 832 306

Mobile
+61 484 340 420

Fax
+61 3 8677 9038

Email
craig@propellhealth.com.au

Postal Address
PO Box 371,
South Yarra VIC 3141
Australia

Online Enquiry

Please call me back
* Required fields

17 Feb 2022  Melbourne

PRESS RELEASE: Propell launches Biofourmis real-time monitoring for Hospital In The Home in Australia

To assist hospitals and healthcare organisations continuously and non-invasively monitor patient vital signs, Propell has partnered with Biofourmis. Propell, the Australian distributor of iHealth, has added Biofourmis to expand the company’s focus on remote patient monitoring. Biofourmis has multiple virtual care monitoring applications including hospital in the home, Emergency Department and chronic condition monitoring. Having established Propell as a leading digital health supplier, the partnership with Biofourmis enables hospitals to engage Propell for all remote monitoring device requirements.

Biofourmis is a US based company with offices in Boston, Singapore, India and Zurich. With over $145 million total in funding (including a $100 million Series C led by SoftBank)raised, Biofourmis is powering personalised predicative care. There are a number of virtual care models to manage patients remotely from acute to post acute, Covid and Hospital In the Home. Major partners include Novartis, AstraZeneca, Mayo Clinic, NHS and the Ministry of Health Singapore.

Biofourmis has a TGA approved medical grade physiology monitor, Biofourmis Everion. The wearable device monitors vital signs including heart rate, heart rate variability, respiration rate, skin temperature, activity and sleep. The device is worn on the arm by the patient. The patient doesn’t need to do anything as the device collects real time data, continuously and non-invasively. No buttons, no cables, no tape and no calibration.

Propell has identified the need for continuous monitoring of patients. Propell’s expertise and experience with remote monitoring devices has identified the gap in the Australian healthcare market. Whilst there are numerous innovative devices available, Propell partnered with Biofourmis after extensive research and discussions by both parties.

With the rising acceptance of virtual care and remote monitoring in Australia, Propell can assist hospitals for short term monitoring. Craig Simmonds, CEO and Founder of Propell states “rather than having nurses continually physically monitor patients who are in the Emergency Department, in post-acute care or in a Hospital in The Home program, Biofourmis can reduce the cost of monitoring and improve real-time data so patients are better monitored”.

14 Feb 2022

 rates iHealth TRACK as best blood pressure monitor in US for 2022.

"This clinically validated blood pressure monitor from iHealth checked all of our boxes, with it's affordable price tag, various data storage solutions and easy-to-read LED display. The standard cuff fits upper arms with diameters ranging from 22 - 42cm, and the extra-large cuff fits upper arms with diameters ranging from 42 cm - 48cm. The monitor runs on battery power too, so you never have to worry about keeping it charged" Feb 2022 

1st Feb 2022

19 Jan 2022

26 October 2021

The Alfred Hospital is helping Covid patients monitor at home using the iHealth Thermometer.

Seen on Channel Nine News 26/10/21, over 1,000 patients are being monitored. "It's incredible to think something so inexpensive and so readily available can give such useful information to help detect deterioration for Covid patients." " Doctors are checking in once a day using telehealth freeing up precious hospital beds."

Sydney Local District and RPA Virtual is using the iHealth AIR Wireless Pulse Oximeter to help monitor patients at home. Jaguar Jones shows how it has helped her health.

 

 

 

 

MEDIA RELEASE

Using technology to remotely monitor chronic disease patients

20th June 2019

Rural patients with high blood pressure, diabetes, heart failure and lung disease can better manage their health from home, with new wearable devices linked to a smart phone app.

Murray PHN has partnered with health technology company Propell, on a pilot study that uses technology to reduce avoidable hospital admissions and improve patient health outcomes for people living with chronic disease.

The trial is being conducted in partnership with Upper Hume Primary Care Partnership and North East Health Wangaratta.

Eligible patients living between Benalla in Victoria and Albury in New South Wales, will be given an individualised care plan - available to them on their smart phone or tablet through the HealthBeats app. Eligibility includes patients who have been admitted to hospital or presented at an Emergency Department in the last six months for the relevant condition.

Using Propell’s iHealth wireless devices, patients will take their own blood pressure, glucose levels, pulse rate and weight readings. Bluetooth technology then connects the iHealth device to the HealthBeats app and uploads the data. The HealthBeats app displays real-time health summary trends and more importantly, allows alerts to be set for missed and abnormal readings.

Over time, this technology will give patients far greater awareness of their condition, understanding what ‘normal’ looks like and what they can do to gain control - for example, patients with chronic pulmonary obstructive disease who have a high blood pressure reading, will be able to identify that they need to do their breathing exercises and potentially lower their next blood pressure reading.

Craig Simmonds, Propell CEO says, “we want to empower patients to take control of their health. People are often accepting of new technology once they see how easy it is and how they benefit. Providing a patient with better understanding of their condition and reducing their anxiety as to their readings, is the value of patient-centred care.”

Murray PHN CEO Matt Jones noted that evidence shows when people are actively involved and supported in their care, it leads to improved outcomes for both the patient and the health system. “We are excited to be trialling this technology, particularly in our rural and regional areas. By identifying and addressing any potential health problems early, we hope that people will remain healthier for longer, avoiding unnecessary travel and costs,” he said.”